|
Re: Trillium
|
7
|
Zenith Epigenetics
|
Aug 25, 2021 10:23PM
|
|
Re: And we wait.......
|
7
|
Resverlogix Corp.
|
Jan 24, 2018 07:11AM
|
|
Re: Private placement
|
7
|
Resverlogix Corp.
|
Aug 30, 2018 12:30PM
|
|
Re: And we wait.......
|
7
|
Resverlogix Corp.
|
Jan 24, 2018 07:34AM
|
|
Re: Is the company trying to exasperate retail investors?
|
7
|
Resverlogix Corp.
|
Jun 30, 2017 11:37AM
|
|
Re: FDA busts Merck's Keytruda in triple-negative breast cancer with a CRL — not unexpected given its disastrous adcomm
|
7
|
Zenith Epigenetics
|
Mar 30, 2021 04:28PM
|
|
Re: We Must Start Planning For a Permanent Pandemic.
|
7
|
Resverlogix Corp.
|
Mar 28, 2021 04:53PM
|
|
Re: New Variant
|
7
|
Resverlogix Corp.
|
Nov 26, 2021 01:58PM
|
|
Long Covid
|
7
|
Resverlogix Corp.
|
Jan 18, 2024 09:07PM
|
|
Re: Corporate Update Webcast and Conference Call December 16, 2021 @ 2 PM MST
|
7
|
Resverlogix Corp.
|
Dec 15, 2021 05:25PM
|
|
Re: Zenith Epigentics and Resverlogix update 22 Jan 2018
|
7
|
Resverlogix Corp.
|
Jan 31, 2018 05:50PM
|
|
Re: My guess is a second BTD is coming
|
7
|
Resverlogix Corp.
|
Feb 08, 2020 02:50PM
|
|
Re: Leading From Behind
|
7
|
Resverlogix Corp.
|
Oct 14, 2020 10:28AM
|
|
Re: RVX ANNOUNCES TYPE C MEETING WITH FDA FOR CORAL, A PHASE 3 HIGH-RISK COVID-19 OUTPATIENT STUDY
|
7
|
Resverlogix Corp.
|
May 09, 2022 05:49PM
|
|
Re: Another country listed on EU Clinical Trial Register for BETonMACE
|
7
|
Resverlogix Corp.
|
Dec 10, 2015 03:04PM
|
|
Re: The MD@A for the period ending July 31, 2017
|
7
|
Resverlogix Corp.
|
Sep 15, 2017 11:25AM
|
|
Re: Zenith Capital Corp. to Present on the Emerging Growth Conference on September 25, 2024
|
7
|
Zenith Epigenetics
|
Sep 27, 2024 03:10PM
|
|
Re: September 24th.
|
7
|
Resverlogix Corp.
|
Sep 24, 2021 12:31PM
|
|
Why the science doesn't sell.... yet (Koo)
|
7
|
Resverlogix Corp.
|
Mar 22, 2016 09:43PM
|
|
Re: Crazy Question
|
7
|
Resverlogix Corp.
|
Jan 06, 2024 10:12AM
|
